Clinical Trial Update: Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)

View source ↗

Summary

The POSEIDON clinical trial evaluating inflammation levels in people with cardiovascular disease has completed. The snippet does not report the study results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease
• Heart Failure

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Cardiovascular Risk, Heart Failure | Status: COMPLETED